Position in NVS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$758,066,781
+$130,893,949 QoQ
Shares Held
4,962,794
+9.1% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 18.057328190531383.ToString("F0")%
Shared 0.ToString("F0")%
None 81.94267180946862.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,125,832 | $10,233,206,495 | |
| 2 | JNJ |
Johnson & Johnson
|
25,516,697 | $6,237,301,411 | |
| 3 | ABBV |
AbbVie Inc.
|
23,936,943 | $5,206,045,728 | |
| 4 | AZN |
Astrazeneca PLC
|
19,058,327 | $3,758,683,247 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,774,221 | $3,701,831,041 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,978,936 | $2,784,464,307 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,586,981 | $1,976,400,394 | |
| 8 | AMGN |
Amgen Inc
|
5,121,028 | $1,801,833,698 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $758,066,781 | 4,962,794 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $627,172,832 | 4,549,016 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $590,657,792 | 4,605,878 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $547,871,319 | 4,527,488 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $525,554,843 | 4,714,342 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $442,644,017 | 4,548,803 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $570,997,233 | 4,964,330 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $515,804,340 | 4,845,053 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $472,834,906 | 4,888,193 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $519,759,833 | 5,147,666 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $529,440,673 | 5,197,729 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $504,043,933 | 4,994,985 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $699,630,652 | 7,604,681 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $577,829,969 | 6,369,378 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $548,577,393 | 7,217,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $627,571,935 | 7,424,251 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $690,218,244 | 7,865,735 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $681,242,424 | 7,788,298 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $753,395,794 | 9,212,470 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $821,309,813 | 9,001,642 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $785,478,451 | 9,189,032 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $926,386,815 | 9,810,302 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $704,430,173 | 8,100,623 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $737,595,991 | 8,445,111 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $713,054,640 | 8,648,328 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||